Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Mirabegron Comparable to Antimuscarinics in Overactive BladderMirabegron is more effective than placebo and as effective as most antimuscarinic monotherapies for treating patients with overactive bladder (OAB), according to an industry-funded systematic review and network meta-analysis.
AUA 2018Read clinically focused news coverage of key developments from AUA 2018.
Medscape Urology, May 7, 2018
Deprescribing Cholinesterase Inhibitors and Memantine The first evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine should lessen clinicians', patients', and families' fear of discontinuing these agents.
